Spandana Sphoorty IPO: Information Analysis IPO AnalysisBy Rajan Gulati 06-Aug-2019 Spandana Sphoorty, the fourth-largest NBFC-MFI in India, has come up with its IPO. Should investors go for it? Here is our analysis.
ICICI Securities' dud IPO tests investing skills of many funds FundwireBy Kumar Shankar Roy 18-Jul-2018 As of June 30, 45 mutual funds from different AMCs hold over 340 lakh shares in the newly listed stock. Read on
Turn of the mid caps StockwireBy Mohammed Ekramul Haque 11-Jan-2016 Mid-sized technology companies have reported higher earnings growth than their larger peers
Magic of media StockwireBy Mohammed Ekramul Haque 08-Jan-2016 The changed political environment spells good news for media, with the industry posting double-digit revenue growth in a subdued economy
Going strong StockwireBy Mohammed Ekramul Haque 06-Jan-2016 Even though the USFDA created problems for large pharma companies, their smaller counterparts have been doing very well
The sweet pill Stock Analyst ChoiceBy Mohammed Ekramul Haque and Vikas Vardhan 03-Dec-2015 Dr Reddy's Laboratories has proved to be one of the best pharma stocks as far as the growth in its revenues and profitability is concerned